GRACE THERAPEUTICS INC

Historical 13F Holders

Symbol
GRCE
CUSIP
00439U104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00439U104 since 12/18/2024, newest first.

Filer % of Class Filed
ADAR1 Capital Management, LLC 13G/A Amendment 6
9.9% 8/14/2026
Event 6/30/2026
Nantahala Capital Management, LLC 13G/A Amendment 3
6.8% 8/14/2026
Event 6/30/2026
Opaleye Management Inc. 13G
13.1% 8/7/2026
Event 8/5/2026
ADAR1 Capital Management, LLC 13G/A Amendment 5
9.9% 5/15/2026
Event 3/31/2026
Orin Hirschman 13G/A Amendment 4
4.9% 4/27/2026
Event 3/31/2026
ADAR1 Capital Management, LLC 13G/A Amendment 4
9.9% 2/17/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A Amendment 2
10.0% 2/13/2026
Event 12/31/2025
Orin Hirschman 13G/A Amendment 3
5.9% 1/28/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A Amendment 1
10.0% 8/14/2025
Event 6/30/2025
Nantahala Capital Management, LLC 13G
10.0% 5/15/2025
Event 3/31/2025
Hirschman Orin 13G/A Amendment 2
9.9% 5/8/2025
Event 3/31/2025
Orin Hirschman 13G/A Amendment 1
5.1% 1/29/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 37 3.95 M $8.97 M
2026 Q1 36 4.26 M $19.7 M
2025 Q4 22 4.33 M $15.0 M
2025 Q3 20 3.71 M $11.0 M
2025 Q2 22 3.82 M $11.3 M
2025 Q1 18 4.02 M $9.17 M
2024 Q4 16 2.09 M $7.84 M
2024 Q3 1 960 k $2.88 M